Compare Aventis Pharma with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs SHASUN PHARMA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA SHASUN PHARMA SANOFI INDIA/
SHASUN PHARMA
 
P/E (TTM) x 41.3 123.9 33.3% View Chart
P/BV x 7.2 8.5 84.8% View Chart
Dividend Yield % 1.2 0.2 516.5%  

Financials

 SANOFI INDIA   SHASUN PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
SHASUN PHARMA
Mar-14
SANOFI INDIA/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs6,84094 7,261.3%   
Low Rs4,63046 10,153.5%   
Sales per share (Unadj.) Rs1,203.1214.2 561.7%  
Earnings per share (Unadj.) Rs165.35.3 3,097.2%  
Cash flow per share (Unadj.) Rs209.915.8 1,326.5%  
Dividends per share (Unadj.) Rs84.001.00 8,400.0%  
Dividend yield (eoy) %1.51.4 102.4%  
Book value per share (Unadj.) Rs963.653.3 1,806.5%  
Shares outstanding (eoy) m23.0356.62 40.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.80.3 1,460.6%   
Avg P/E ratio x34.713.1 264.9%  
P/CF ratio (eoy) x27.34.4 618.5%  
Price / Book Value ratio x6.01.3 454.2%  
Dividend payout %50.818.7 271.2%   
Avg Mkt Cap Rs m132,0783,958 3,337.2%   
No. of employees `0003.3NA-   
Total wages/salary Rs m4,0682,164 188.0%   
Avg. sales/employee Rs Th8,393.8NM-  
Avg. wages/employee Rs Th1,232.4NM-  
Avg. net profit/employee Rs Th1,153.0NM-  
INCOME DATA
Net Sales Rs m27,70812,127 228.5%  
Other income Rs m897229 391.1%   
Total revenues Rs m28,60512,356 231.5%   
Gross profit Rs m6,2351,009 617.9%  
Depreciation Rs m1,027594 173.0%   
Interest Rs m7415 1.7%   
Profit before tax Rs m6,098230 2,654.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292-73 -3,151.8%   
Profit after tax Rs m3,806302 1,259.8%  
Gross profit margin %22.58.3 270.4%  
Effective tax rate %37.6-31.7 -118.7%   
Net profit margin %13.72.5 551.4%  
BALANCE SHEET DATA
Current assets Rs m15,9226,884 231.3%   
Current liabilities Rs m6,2358,456 73.7%   
Net working cap to sales %35.0-13.0 -269.8%  
Current ratio x2.60.8 313.7%  
Inventory Days Days6462 103.3%  
Debtors Days Days21108 19.4%  
Net fixed assets Rs m7,5394,970 151.7%   
Share capital Rs m230113 203.0%   
"Free" reserves Rs m21,9622,875 763.9%   
Net worth Rs m22,1923,020 734.8%   
Long term debt Rs m01,817 0.0%   
Total assets Rs m29,83913,347 223.6%  
Interest coverage x872.11.6 56,145.5%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.90.9 102.2%   
Return on assets %12.85.4 237.8%  
Return on equity %17.210.0 171.4%  
Return on capital %27.513.3 206.5%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m7,5875,843 129.9%   
Fx outflow Rs m7,1452,173 328.8%   
Net fx Rs m4423,669 12.0%   
CASH FLOW
From Operations Rs m3,739398 940.4%  
From Investments Rs m-731-1,635 44.7%  
From Financial Activity Rs m-1,9721,309 -150.7%  
Net Cashflow Rs m1,03671 1,455.1%  

Share Holding

Indian Promoters % 0.0 39.2 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 3.6 400.0%  
FIIs % 14.6 17.6 83.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 39.6 26.5%  
Shareholders   15,184 20,750 73.2%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   FDC LTD.  UNICHEM LAB  WYETH LTD  AJANTA PHARMA  ALEMBIC LTD  

Compare SANOFI INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Rising Inflation and Onion Effect: Your Inside Scoop on the Markets(Podcast)

Stock markets remained rangebound this week too. Macroeconomic news globally and domestically remained the focus of the week.

Related Views on News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Dec 13, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS